Personal tools

MCL coexpression mm9:114

From FANTOM5_SSTAR

Revision as of 16:10, 10 October 2012 by Autoedit (talk | contribs) (Created page with "{{MCL_coexpression_mm9|gostat_on_MCL_coexpression=GO:0035094;response to nicotine;5.90605161753699e-05;110835,108015,110834!GO:0007271;synaptic transmission, cholinergic;0.000...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Phase1 CAGE Peaks

 Short description
Mm9::chr10:31329624..31329676,-p3@Rnf217
Mm9::chr11:35358024..35358067,+p4@Slit3
Mm9::chr11:43342261..43342298,+p1@Ccnjl
Mm9::chr11:43342307..43342322,+p2@Ccnjl
Mm9::chr11:43400570..43400574,+p1@4933415A04Rik
Mm9::chr11:66725485..66725505,+p1@Pirt
Mm9::chr11:66725506..66725546,+p2@Pirt
Mm9::chr11:66725554..66725573,+p3@Pirt
Mm9::chr11:94816723..94816733,+p@chr11:94816723..94816733
+
Mm9::chr11:96164821..96164865,+p1@Hoxb5
Mm9::chr11:96164868..96164875,+p5@Hoxb5
Mm9::chr11:96175972..96175978,+p@chr11:96175972..96175978
+
Mm9::chr11:96176093..96176104,+p@chr11:96176093..96176104
+
Mm9::chr11:96176110..96176149,+p@chr11:96176110..96176149
+
Mm9::chr14:104214967..104214980,-p@chr14:104214967..104214980
-
Mm9::chr14:104242355..104242372,-p@chr14:104242355..104242372
-
Mm9::chr14:104243404..104243415,-p12@Ednrb
Mm9::chr14:104243425..104243438,-p6@Ednrb
Mm9::chr14:104243463..104243484,-p4@Ednrb
Mm9::chr14:104243485..104243515,-p3@Ednrb
Mm9::chr14:104243517..104243522,-p14@Ednrb
Mm9::chr14:104243531..104243557,-p2@Ednrb
Mm9::chr14:17407549..17407575,-p3@Rarb
Mm9::chr15:102928215..102928218,-p@chr15:102928215..102928218
-
Mm9::chr15:102932532..102932548,-p@chr15:102932532..102932548
-
Mm9::chr15:102998460..102998477,-p2@Smug1
Mm9::chr16:38910223..38910228,+p@chr16:38910223..38910228
+
Mm9::chr17:15966789..15966803,-p@chr17:15966789..15966803
-
Mm9::chr17:15966846..15966866,-p@chr17:15966846..15966866
-
Mm9::chr17:68273854..68273859,-p@chr17:68273854..68273859
-
Mm9::chr17:75404863..75404905,+p1@Ltbp1
Mm9::chr18:25224581..25224593,+p7@Fhod3
Mm9::chr18:25224624..25224637,+p8@Fhod3
Mm9::chr18:43367378..43367391,+p4@LOC100047004
p4@Stk32a
Mm9::chr18:43425442..43425450,+p@chr18:43425442..43425450
+
Mm9::chr18:43488317..43488321,-p@chr18:43488317..43488321
-
Mm9::chr18:43598025..43598036,-p9@Dpysl3
Mm9::chr18:4980585..4980596,+p@chr18:4980585..4980596
+
Mm9::chr18:4980598..4980625,+p@chr18:4980598..4980625
+
Mm9::chr18:84257094..84257108,-p@chr18:84257094..84257108
-
Mm9::chr18:89035657..89035660,-p@chr18:89035657..89035660
-
Mm9::chr19:3414464..3414481,-p1@Gal
Mm9::chr1:92965124..92965151,+p@chr1:92965124..92965151
+
Mm9::chr2:119586145..119586157,-p2@Ltk
Mm9::chr2:119624214..119624225,+p7@Tyro3
Mm9::chr2:31305411..31305419,+p@chr2:31305411..31305419
+
Mm9::chr2:4480691..4480702,+p17@Frmd4a
Mm9::chr2:4480747..4480752,+p41@Frmd4a
Mm9::chr2:44946359..44946364,-p@chr2:44946359..44946364
-
Mm9::chr2:67492047..67492052,+p@chr2:67492047..67492052
+
Mm9::chr2:74565247..74565258,+p3@Hoxd4
Mm9::chr2:74565306..74565327,+p2@Hoxd4
Mm9::chr2:74583733..74583738,+p13@Hoxd3
Mm9::chr2:74583741..74583750,+p10@Hoxd3
Mm9::chr2:74583776..74583815,+p3@Hoxd3
Mm9::chr4:109965106..109965109,-p@chr4:109965106..109965109
-
Mm9::chr4:109965324..109965337,-p13@Elavl4
Mm9::chr4:149668115..149668119,+p@chr4:149668115..149668119
+
Mm9::chr4:98484378..98484397,-p1@Kank4
Mm9::chr5:118291893..118291934,+p1@Nos1
Mm9::chr5:118291939..118291948,+p5@Nos1
Mm9::chr5:135965066..135965107,-p@chr5:135965066..135965107
-
Mm9::chr5:45167917..45167920,-p@chr5:45167917..45167920
-
Mm9::chr5:46030607..46030647,-p1@Fam184b
Mm9::chr5:46030683..46030696,-p6@Fam184b
Mm9::chr5:67359798..67359814,+p3@Limch1
Mm9::chr5:67486110..67486118,-p@chr5:67486110..67486118
-
Mm9::chr5:67487233..67487235,-p@chr5:67487233..67487235
-
Mm9::chr5:67489910..67489925,+p@chr5:67489910..67489925
+
Mm9::chr5:67490284..67490302,-p1@Phox2b
Mm9::chr5:67490333..67490342,-p5@Phox2b
Mm9::chr5:67490346..67490357,-p4@Phox2b
Mm9::chr5:67490391..67490404,-p3@Phox2b
Mm9::chr5:67490412..67490421,-p6@Phox2b
Mm9::chr5:67597048..67597059,+p@chr5:67597048..67597059
+
Mm9::chr6:118105351..118105370,-p@chr6:118105351..118105370
-
Mm9::chr6:118116455..118116458,-p@chr6:118116455..118116458
-
Mm9::chr6:118147336..118147353,-p1@Ret
Mm9::chr6:118147365..118147366,-p5@Ret
Mm9::chr6:118147374..118147392,-p2@Ret
Mm9::chr6:118147404..118147415,-p3@Ret
Mm9::chr6:118147750..118147761,-p7@Ret
Mm9::chr6:118147768..118147779,-p6@Ret
Mm9::chr6:118147812..118147826,-p4@Ret
Mm9::chr7:138703922..138703933,+p2@Bub3
Mm9::chr7:138703939..138703942,+p3@Bub3
Mm9::chr7:38376166..38376169,-p@chr7:38376166..38376169
-
Mm9::chr7:54051521..54051526,+p4@Gtf2h1
Mm9::chr7:94427398..94427402,+p@chr7:94427398..94427402
+
Mm9::chr7:98820891..98820900,+p34@Dlg2
Mm9::chr7:98821147..98821167,+p26@Dlg2
Mm9::chr8:11912972..11913001,+p@chr8:11912972..11913001
+
Mm9::chr8:59799533..59799566,-p@chr8:59799533..59799566
-
Mm9::chr9:109735573..109735587,+p5@Nme6
Mm9::chr9:48719025..48719051,-p@chr9:48719025..48719051
-
Mm9::chr9:48719172..48719183,-p1@Htr3a
Mm9::chr9:48719225..48719245,-p3@Htr3a
Mm9::chr9:54829289..54829303,+p2@Chrna5
Mm9::chr9:54874331..54874346,-p2@Chrna3
Mm9::chr9:54874348..54874406,-p1@Chrna3
Mm9::chr9:54891807..54891824,-p@chr9:54891807..54891824
-
Mm9::chr9:54896368..54896400,-p2@Chrnb4
Mm9::chr9:54896555..54896599,-p1@Chrnb4
Mm9::chr9:65619254..65619257,-p@chr9:65619254..65619257
-
Mm9::chrX:56821245..56821271,-p2@Fgf13


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data



Relative expression of the co-expression cluster over median <br>Analyst:


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:114&oldid=2141850"